Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment

Acta Pharm Sin B. 2020 Jul;10(7):1249-1250. doi: 10.1016/j.apsb.2020.05.006. Epub 2020 May 26.

Tianru Jin^{1

2

3

4

5}, Mingyao Liu^{1

2

3

4

6}

¹ Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 1V7, Canada.
² Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 1V7, Canada.
³ Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 1V7, Canada.
⁴ Toronto General Hospital Research Institute, University Health Network, Toronto, ON, M5G 1V7, Canada.
⁵ Best Diabetes Centre, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 1V7, Canada.
⁶ Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, ON, M5G 1V7, Canada.

No abstract available